Bulletin du cancer 2013-05-01

[A posteriori biological demonstration of the concept of hormone-radiotherapy combination in cancer of the prostate].

Nicolas Magné

Index: Bull. Cancer 100(5) , 415-6, (2013)

Full Text: HTML

Abstract

Structure	Name/CAS No.	Molecular Formula	Articles
	Leuprolide TFA CAS:53714-56-0	C₅₉H₈₄N₁₆O₁₂
	(Des-Gly10,D-Leu6,Pro-NHEt9)-LHRH acetate salt CAS:74381-53-6	C₆₁H₈₈N₁₆O₁₄

Estradiol, but not testosterone, heightens cortisol-mediated...
2014-05-01
[Am. J. Physiol. Regul. Integr. Comp. Physiol. 306(9) , R627-35, (2014)]

Two different formulations with equivalent effect? Compariso...
2013-03-01
[Med. Oncol. 30(1) , 354, (2013)]

Novasure as a mechanical endometrial preparation agent in la...
2012-01-01
[JSLS 16(4) , 537-41, (2012)]

Comprehensive management of diffuse leiomyomatosis in a pati...
2013-12-01
[P. R. Health Sci. J. 32(4) , 200-2, (2013)]

A rare case of lymphangiomyomatosis treated with leuprolide ...
2013-01-01
[Eur. J. Gynaecol. Oncol. 34(3) , 278-9, (2013)]

[A posteriori biological demonstration of the concept of hormone-radiotherapy combination in cancer of the prostate].

Abstract

Related Compounds